Half-century-old TB drugs get a facelift in new cocktails
The first-line regime of tuberculosis drugs has remained virtually unchanged for a half century. But instead of improving on these […]
The first-line regime of tuberculosis drugs has remained virtually unchanged for a half century. But instead of improving on these […]
Tuberculosis is the leading killer of HIV patients. The three groups working for new TB tools—TB Alliance, Aeras and FIND—asked
The past decade has seen significant progress in scaling up effective treatment and case management programs for tuberculosis (TB) control,
GENEVA – Health authorities worldwide must do more to combat tuberculosis, which killed an estimated 1.7 million people last year,
· First clinical trial to test multiple new TB drugs in combination · Potential for one TB drug regimen to
The TB Alliance is delighted to announce the election of four new organizational members of its Stakeholders Association. We welcome
AstraZeneca’s chief executive will this week urge ministers to work with the pharmaceutical industry to share the risks and costs
The U.S. Food and Drug Administration today announced the award of $2.9 million to support six research projects that will
The 4th Open Forum Conference was held in Addis Ababa, Ethiopia on 18th and 19th August to address key issues
[New York, United States and Geneva, Switzerland, July 7, 2010] The Global Alliance for TB Drug Development (TB Alliance) and